Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127252491 | 12725249 | 1 | I | 20140605 | 20140612 | 20160908 | 20160908 | EXP | US-PFIZER INC-2014163007 | PFIZER | 59.00 | YR | F | Y | 39.00000 | KG | 20160908 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127252491 | 12725249 | 1 | PS | CYTARABINE. | CYTARABINE | 1 | Intravenous (not otherwise specified) | 210 MG, CONTINUOUS INFUSION ON DAYS 1-7 | 71868 | 210 | MG | ||||||||
| 127252491 | 12725249 | 2 | SS | CYTARABINE. | CYTARABINE | 1 | Intravenous (not otherwise specified) | 2090 MG, CONTINUOUS INFUSION ON DAYS 1-7 | 71868 | 2090 | MG | ||||||||
| 127252491 | 12725249 | 3 | SS | PF-04449913 | GLASDEGIB | 1 | Oral | 100 MG, ONCE DAILY CONTINUOUS | 0 | 100 | MG | TABLET | QD | ||||||
| 127252491 | 12725249 | 4 | SS | DAUNORUBICIN | DAUNORUBICIN | 1 | Intravenous (not otherwise specified) | 127 MG, CYCLIC, DAY 1-3 | 0 | 127 | MG | ||||||||
| 127252491 | 12725249 | 5 | C | ACYCLOVIR. | ACYCLOVIR | 1 | UNK | 0 | |||||||||||
| 127252491 | 12725249 | 6 | C | MAALOX ANTACID | ALUMINUM HYDROXIDEDIMETHICONEMAGNESIUM HYDROXIDE | 1 | UNK | 0 | |||||||||||
| 127252491 | 12725249 | 7 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | UNK | 0 | |||||||||||
| 127252491 | 12725249 | 8 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | UNK | 0 | |||||||||||
| 127252491 | 12725249 | 9 | C | HEPARIN FLUSH | HEPARIN SODIUM | 1 | UNK | 0 | |||||||||||
| 127252491 | 12725249 | 10 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | UNK | 0 | |||||||||||
| 127252491 | 12725249 | 11 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | UNK | 0 | |||||||||||
| 127252491 | 12725249 | 12 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 127252491 | 12725249 | 13 | C | VANCOMYCIN | VANCOMYCIN | 1 | UNK | 0 | |||||||||||
| 127252491 | 12725249 | 14 | C | LEVAQUIN | LEVOFLOXACIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127252491 | 12725249 | 1 | Acute myeloid leukaemia |
| 127252491 | 12725249 | 3 | Acute myeloid leukaemia |
| 127252491 | 12725249 | 4 | Acute myeloid leukaemia |
| 127252491 | 12725249 | 5 | Prophylaxis |
| 127252491 | 12725249 | 6 | Gastrooesophageal reflux disease |
| 127252491 | 12725249 | 7 | Supplementation therapy |
| 127252491 | 12725249 | 8 | Depression |
| 127252491 | 12725249 | 9 | Catheter management |
| 127252491 | 12725249 | 10 | Hypothyroidism |
| 127252491 | 12725249 | 11 | Hypertension |
| 127252491 | 12725249 | 12 | Nausea |
| 127252491 | 12725249 | 13 | Clostridium difficile infection |
| 127252491 | 12725249 | 14 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127252491 | 12725249 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127252491 | 12725249 | Abdominal pain | |
| 127252491 | 12725249 | Confusional state | |
| 127252491 | 12725249 | Diarrhoea | |
| 127252491 | 12725249 | Febrile neutropenia | |
| 127252491 | 12725249 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127252491 | 12725249 | 1 | 20140227 | 20140305 | 0 | |
| 127252491 | 12725249 | 2 | 20140527 | 0 | ||
| 127252491 | 12725249 | 3 | 20140224 | 0 | ||
| 127252491 | 12725249 | 4 | 20140227 | 20140301 | 0 |